Skip to main content

FOCIS 2022 Main banner

ViewAttendees 4

Translational Learnings from BCMA and CD19 CART Cells

Thursday, June 23, 2022

11:00 AM – 11:25 AM PT

Location: Salon 8

Speaker(s)

Kristen Hege, MD

Sr Vice President, Early Clinical Development, Hematology/Oncology & Cell Therapy
Bristol Myers Squibb
San Francisco, California, United States

PDF

Chair(s)

LB

Lisa Butterfield, PhD

Learning Objectives:

understand the clinical activity of BCMA and CD19 directed CAR T cells
gain translational insights from CAR T cell clinical trials
learn how these translational insights guide the next generation of cell therapy development